share_log

Ardelyx | 8-K: Current report

Ardelyx | 8-K: Current report

Ardelyx | 8-K:重大事件
美股sec公告 ·  05/23 17:02
Moomoo AI 已提取核心訊息
Ardelyx, Inc., a biopharmaceutical company traded on the Nasdaq Global Market under the symbol ARDX, has filed a Form 8-K with the U.S. Securities and Exchange Commission on May 22, 2024. The report announces the resignation of Susan Rodriguez from her position as Chief Commercial Officer of Ardelyx. The decision was mutually agreed upon by both parties. To ensure a smooth transition, Ms. Rodriguez will continue to serve in an advisory capacity to the company until the end of 2024. The company's headquarters are located in Waltham, Massachusetts, and it is incorporated in the state of Delaware. No other material events, financial statements, or exhibits were disclosed in the filing.
Ardelyx, Inc., a biopharmaceutical company traded on the Nasdaq Global Market under the symbol ARDX, has filed a Form 8-K with the U.S. Securities and Exchange Commission on May 22, 2024. The report announces the resignation of Susan Rodriguez from her position as Chief Commercial Officer of Ardelyx. The decision was mutually agreed upon by both parties. To ensure a smooth transition, Ms. Rodriguez will continue to serve in an advisory capacity to the company until the end of 2024. The company's headquarters are located in Waltham, Massachusetts, and it is incorporated in the state of Delaware. No other material events, financial statements, or exhibits were disclosed in the filing.
Ardelyx, Inc. 是一家在納斯達克全球市場上市的生物製藥公司,股票代碼爲ARDX,該公司已於2024年5月22日向美國證券交易委員會提交了8-K表格。該報告宣佈蘇珊·羅德里格斯辭去Ardelyx首席商務官的職務。該決定是雙方共同商定的。爲確保平穩過渡,羅德里格斯女士將繼續以顧問身份在公司任職至2024年底。該公司的總部位於馬薩諸塞州沃爾瑟姆,並在特拉華州註冊成立。申報中沒有披露其他重大事件、財務報表或證物。
Ardelyx, Inc. 是一家在納斯達克全球市場上市的生物製藥公司,股票代碼爲ARDX,該公司已於2024年5月22日向美國證券交易委員會提交了8-K表格。該報告宣佈蘇珊·羅德里格斯辭去Ardelyx首席商務官的職務。該決定是雙方共同商定的。爲確保平穩過渡,羅德里格斯女士將繼續以顧問身份在公司任職至2024年底。該公司的總部位於馬薩諸塞州沃爾瑟姆,並在特拉華州註冊成立。申報中沒有披露其他重大事件、財務報表或證物。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息